Lv5
1367 积分 2021-03-23 加入
Human Amylin: From Pathology to Physiology and Pharmacology
20小时前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
10天前
已完结
获得性长QT间期综合征的防治建议
10天前
已完结
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
11天前
已关闭
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
15天前
已完结
Long-acting amylin analogues for the management of obesity
20天前
已完结
Amylin: Pharmacology, Physiology, and Clinical Potential
20天前
已完结
Amylin analogs for the treatment of obesity without diabetes: present and future
20天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
1个月前
已完结
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis
1个月前
已完结
皖公网安备34019202002308
